Pediatrics Doctors in Bolingbrook, IL Accepting Medicare
6 Pediatrics doctors found. Showing 1 - 6
 Youssef E Akl, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 550 E Boughton Rd, Suite 110, Bolingbrook, IL 60440 Phone: 630-783-0044 Fax: 630-783-1961 |
 Dr. Manju M Akhand, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 391 Quadrangle Dr, Suite N2, Bolingbrook, IL 60440 Phone: 630-679-1275 Fax: 630-679-1276 |
Dr. Paramjeet Kaur Singh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 439 W Boughton Rd, Bolingbrook, IL 60440 Phone: 630-759-5000 Fax: 630-759-4567 |
Moazzam Saeed, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 215 Remington Blvd Ste B, Bolingbrook, IL 60440 Phone: 630-226-5300 Fax: 815-461-0213 |
Dr. Anjum Yousuf, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 550 E Boughton Road, Suite 110, Bolingbrook, IL 60440 Phone: 630-783-0044 Fax: 630-783-1961 |
Efrain Flores, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 215 Remington Blvd, Suite H, Bolingbrook, IL 60440 Phone: 630-226-9407 |
News Archive
Therapeutic hypothermia reduces in-hospital deaths among sudden cardiac arrest patients
Forced body cooling known as therapeutic hypothermia has reduced in-hospital deaths among sudden cardiac arrest patients nearly 12 percent between 2001 and 2009, according to a Mayo Clinic study being presented at the upcoming American Academy of Neurology 2012 Annual Meeting in New Orleans.
NSAIDs can reduce colorectal cancer risk
A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer.
Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19
Texas Biomedical Research Institute in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.
SARS-CoV-2 D614G variant enhances infectivity, replication and transmission
Researchers in the United States and Japan have conducted a study showing a common mutation in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVD-19) - enhances the infectivity, replication, and early transmission of the virus.
› Verified 9 days ago
Internal Medicine
Family Medicine
Anesthesiology
Hospitalist
Obstetrics & Gynecology
Emergency Medicine
Pediatrics
Ophthalmology
Surgery
Orthopaedic Surgery